South San Francisco, CA September 26, 2022 Press Release Futurelab+ is a $10 Million Expansion of Genentech’s Original South San Francisco Futurelab Program South San Francisco, CA – September 26, 2022 – Genentech, a member of the Roche…
Tag: Biotechnology
Biocom California Statement on New Drug Pricing Legislation
South San Francisco, CA August 8, 2022 Press Release Note: As South San Francisco boasts the recognition of being the birthplace of biotechnology and home to one of the largest consolidations of life science businesses, this press release is important…
Pliant Therapeutics Announces Proposed Public Offering of Common Stock
South San Francisco, CA July 12, 2022 Press Release Pliant Therapeutics, Inc. (Nasdaq: PLRX), a clinical stage biotechnology company focused on discovering and developing novel therapeutics for the treatment of fibrosis, today announced that it has commenced an underwritten public offering of…
More Biotechs Moving to South San Francisco?
South San Francisco CA, April 19, 2022 ESC Correspondent Allie Saults Are more biotechs coming to South San Francisco? South San Francisco has been many things; from farmland to meatpacking to steel manufacturing, and today our City is proudly known…
AbbVie Launches New Facility in South San Francisco, Birthplace of Biotech
South San Francisco, CA April 12, 2022 Press Release, h/t to Matt Skryja Ready, set, launch: AbbVie opens new facility in the Bay Area In the birthplace of biotech, we’re continuing our investment in innovation. There’s a new addition to…
San Mateo County to Lift Most Indoor Mask Mandates on February 16
South San Francisco, CA February 15, 2022 Submitted by County of San Mateo Eleven Bay Area Health Officers to Lift Most Indoor Mask Mandates on February 16 Masks still strongly recommended; vaccines and boosters urged to further strengthen defenses In…
The Transformation of Oyster Point in South San Francisco
South San Francisco, CA April 5, 2021 by Mel Ellison, ESC Correspondent Oyster Point Morphs and Dwarfs The San Mateo County Harbor District held a special meeting and site tour at the Oyster Point Marina on Thursday, March 4th and…
MBA Information Session for Biotech Professionals in South San Francisco on February 26th
South San Francisco, CA February 20, 2020 San Francisco State University has a Biotech MBA program based in Downtown South San Francisco and the public is invited to learn more about this program during a presentation on February 26th from…
Complexities of Patents in Biotechnology
South San Francisco, CA February 20, 2020 by Filip Kovacevic, Special Correspondent What is Biotechnology? The research behind biotechnology helps heal the world by harnessing what’s provided in nature. In a way, it is using resources found in nature…
Phase III IMpower150 Study Showed Genentech’s Tecentriq (Atezolizumab) and Avastin (Bevacizumab) Plus Chemotherapy Significantly Reduced the Risk of Disease Worsening or Death in the Initial Treatment of People with a Type of Advanced Lung Cancer
South San Francisco, CA November 29, 2017 Genentech Press Release – Data will be submitted to health authorities globally, including the U.S. Food and Drug Administration (FDA) and European Medicines Agency (EMA) – SOUTH SAN FRANCISCO, CA — 2017-11-19 00:00:00 Genentech,…